News
-
-
PRESS RELEASE
StageZero Life Sciences Announces Update on Failure to File Cease Trade Order
StageZero Life Sciences, Ltd. remains under a Failure to File Cease Trade Order (FFCTO) following delay in filing 2023 financials. The company aims to file before July 3, 2024, and confirms no undisclosed material information -
-
-
-
PRESS RELEASE
StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order
StageZero Life Sciences announces denial of voluntary management cease trade order application by the Ontario Securities Commission due to anticipated delay in filing financial statements for December 31, 2023 -
-
PRESS RELEASE
StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results
StageZero Life Sciences, Ltd. announces a delay in filing its audited financial statements for 2023, cites financial resource constraints. Company applies for Management Cease Trade Order from Ontario Securities Commission -
-
-
LaMar’s Donuts Celebrates National Donut Day 2024
-
abrdn U.S. Closed-End Funds Announce Distribution Payment Details
-
abrdn Income Credit Strategies Fund Announces Update and Tentative Closing Date for Acquisition of Assets From First Trust High Income Long/Short Fund
-
Electric Royalties Announces Interest Conversion Under Convertible Credit Facility
-
Pfister Faucets' American Plumber Stories Docuseries Wins Three Telly Awards
-
EQS-Adhoc: Vectron Systems AG: Vectron enters into Business Combination Agreement, resolves 10% capital increase without subscription rights of the shareholders and supports voluntary public acqusition offer
-
CPI PROPERTY GROUP publishes financial results for the first quarter of 2024
-
Leclanché SA: Publishes its Annual Report 2023 and Non-financial ESG Report
-
Spexis receives second extension for the publication of its 2023 annual report until July 31, 2024, releasing its unaudited financial statements and providing an update on its dispute with SPRIM.
-
Molten Ventures Plc: HOL-Holding(s) in Company
-
ACCOR - Description of own share buyback programme
-
ACCOR - Press release following the 2024 general meeting
-
Capital increase through exercise of subscription rights
-
NFL BIOSCIENCES: RESULTS OF THE COMBINED GENERAL MEETING OF MAY 30, 2024
-
Thales has completed the sale of its Ground Transportation Systems business